Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jadwiga K. Kepa"'
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e44861 (2012)
NAD(P)H:quinone oxidoreductase 1 (NQO1) is an FAD containing quinone reductase that catalyzes the 2-electron reduction of a broad range of quinones. The 2-electron reduction of quinones to hydroquinones by NQO1 is believed to be a detoxification proc
Externí odkaz:
https://doaj.org/article/9e9acc21d74941ae88af12d8800c8e47
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 336:874-880
Previous work demonstrated that NAD(P)H:quinone oxidoreductase 1 (NQO1) metabolized the heat shock protein 90 (Hsp90) inhibitor 17-(allylamino)-17-demethoxygeldanamycin (17AAG) to the corresponding hydroquinone (17AAGH₂). The formation of 17AAGH₂
Publikováno v:
Molecular Pharmacology. 74:1657-1665
2,5-Diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone (RH1) is a novel antitumor diaziridinyl benzoquinone derivative designed to be bioactivated by the two-electron reductase NAD(P)H:quinone oxidoreductase (NQO1) and is currently in clinical
Autor:
David Siegel, Andrea L. Merz, Michael E. Long, David Ross, Jeffrey C. Rastatter, Daniel L. Gustafson, Jadwiga K. Kepa, Jacqueline C. Parpal
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 305:1079-1086
The bioreductive activation of the antitumor quinone mitomycin C (MMC) by NAD(P)H: quinone oxidoreductase 1 (NQO1) is complicated by the ability of MMC to also act as a mechanism-based inhibitor of NQO1 in a pH dependent manner. Inhibition of NQO1 by
Autor:
David Siegel, David Ross, Luo Jia Tang, Jadwiga K. Kepa, Donna L. Dehn, Adil Anwar, Jennifer A. Pietenpol
Publikováno v:
Journal of Biological Chemistry. 278:10368-10373
NAD(P)H:quinone oxidoreductase 1 (NQO1) has been proposed to stabilize p53 via a redox mechanism involving oxidation of NAD(P)H as a consequence of the catalytic activity of NQO1. We report that treatment of HCT-116 human colon carcinoma cells with t
Publikováno v:
Chemico-Biological Interactions. 129:77-97
NAD(P)H:quinone oxidoreductase 1 (NQO1) is an obligate two-electron reductase that is involved in chemoprotection and can also bioactivate certain antitumor quinones. This review focuses on detoxification reactions catalyzed by NQO1 and its role in a
Autor:
Jadwiga K. Kepa, Philip Reigan, Andrew M. Donson, Christopher C. Franklin, Dennis R. Petersen, Kristofer S. Fritz, Nicholas K. Foreman, Donald S. Backos, Debbie G. McArthur
Publikováno v:
Neurochemical research. 38(9)
The antioxidant glutathione (GSH) plays a critical role in maintaining intracellular redox homeostasis but in tumors the GSH biosynthetic pathway is often dysregulated, contributing to tumor resistance to radiation and chemotherapy. Glutamate-cystein
Autor:
Eric A. Boen, Glenn S. Takimoto, Paul Prendergast, Jadwiga K. Kepa, Margaret E. Wierman, Dean P. Edwards, Britta M. Jacobsen
Publikováno v:
Molecular and Cellular Endocrinology. 117:27-39
The mechanisms by which steroid receptors repress gene expression are not well understood. In this report, we show that progesterone receptor (PR), in the presence of progesterone (P) directly represses rat gonadotropin releasing hormone (rGnRH) gene
Publikováno v:
Cellular and Molecular Neurobiology. 15:79-88
1. Gonadotropin-releasing hormone (GnRH) is the hypothalamic releasing factor that controls pituitary gonadotropin subunit gene expression and indirectly gametogenesis and steroidogenesis from the gonad, which results in reproductive competence. 2. G
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 334(1)
NAD(P)H:quinone oxidoreductase 1 (NQO1) deficiency resulting from a homozygous NQO1*2 polymorphism has been associated with an increased risk of benzene-induced myeloid toxicity and a variety of de novo and therapy-induced leukemias. Endothelial cell